CAS No. |
1303607-60-4 |
中文名称 |
Sar405838(该名称为研发代号/非IUPAC系统命名;需提供完整英文IUPAC系统名或结构信息(如SMILES/InChI)以生成符合CCS的标准中文系统名) |
英文名称 |
SAR405838 |
别名 |
(2'R,3R,3'S,5'S)-6-chloro-3'-(3-chloro-2-fluorophenyl)-5'-(2,2-dimethylpropyl)-N-(4-hydroxycyclohexyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide | 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl-, (6R)- (9CI) | SCHEMBL5585402 | DB12541 | MI773 | A |
标准英文名 |
(2'S,3R,4'S,5'R)-6-chloro-4'-(3-chloro-2-fluorophenyl)-N-((1r,4R)-4-hydroxycyclohexyl)-2'-neopentyl-2-oxospiro[indoline-3,3'-pyrrolidine]-5'-carboxamide |
MDL No. |
MFCD28976052 |
分子式 |
C29H34Cl2FN3O3 |
分子量 |
562.51
|
精确分子量 |
561.20
|
SMILES |
CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2CC[C@H](O)CC2)[C@H](C2=CC=CC(Cl)=C2F)[C@]12C(=O)NC1=C2C=CC(Cl)=C1 |
标准SMILES |
CC(C)(C)C[C@@H]1N[C@H]([C@H](C2=CC=CC(Cl)=C2F)[C@]21C1C=CC(Cl)=CC=1NC2=O)C(=O)N[C@@H]1CC[C@@H](O)CC1 |
用途 |
SAR405838 (MI-773) is an orally bioavailable MDM2 antagonist with a Ki of 0.88 nM, currently in Phase 1 clinical trials; it effectively inhibits the proliferation of SJSA-1, RS4;11, LNCaP, and HCT-116 tumor cells with IC50 values of 0.092 μM, 0.089 μM, 0.27 μM, and 0.20 μM, respectively; it demonstrates high selectivity against p53-mutant or p53-knockout tumor cell lines, including SAOS-2, PC-3, SW620, and HCT-116 (p53−/−), with IC50 values >10 μM, >10 μM, >10 μM, and >20 μM, respectively; in vivo, it dose-dependently inhibits tumor growth in xenograft models of SJSA-1 osteosarcoma, RS4;11 acute lymphoblastic leukemia, LNCaP prostate cancer, and HCT-116 colon cancer at oral doses of 10, 30, 50, 100, and 200 mg/kg. |
InChIKey |
IDKAKZRYYDCJDU-HBMMIIHUSA-N |